Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The price of Alignment Healthcare Inc (NASDAQ: ALHC) closed at $5.08 in the last session, down -2.50% from day before closing price of $5.21. In other words, the price has decreased by -$2.50 from its previous closing price. On the day, 0.58 million shares were traded. ALHC stock price reached its highest trading level at $5.36 during the session, while it also had its lowest trading level at $5.065.
Ratios:
We take a closer look at ALHC’s different ratios to gain a better understanding of the stock. In the meantime, Its Debt-to-Equity ratio is 1.16 whereas as Long-Term Debt/Eq ratio is at 1.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on March 06, 2024, initiated with a Underweight rating and assigned the stock a target price of $4.50.
On March 06, 2024, Piper Sandler Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $12 to $6.
On January 24, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $11.Stifel initiated its Buy rating on January 24, 2024, with a $11 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 28 ’24 when Maroney Dawn Christine sold 10,151 shares for $4.84 per share. The transaction valued at 49,131 led to the insider holds 1,976,097 shares of the business.
Kardes Hakan sold 4,363 shares of ALHC for $21,117 on Mar 28 ’24. The Chief Experience Officer now owns 430,444 shares after completing the transaction at $4.84 per share. On Mar 28 ’24, another insider, Freeman Robert Thomas, who serves as the Chief Financial Officer of the company, sold 4,299 shares for $4.84 each. As a result, the insider received 20,807 and left with 865,407 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 984575104 and an Enterprise Value of 814817536. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.53 while its Price-to-Book (P/B) ratio in mrq is 6.12. Its current Enterprise Value per Revenue stands at 0.447 whereas that against EBITDA is -7.816.
Stock Price History:
The Beta on a monthly basis for ALHC is 1.25, which has changed by -0.2507375 over the last 52 weeks, in comparison to a change of 0.24191546 over the same period for the S&P500. Over the past 52 weeks, ALHC has reached a high of $9.20, while it has fallen to a 52-week low of $4.46. The 50-Day Moving Average of the stock is -3.29%, while the 200-Day Moving Average is calculated to be -21.24%.
Shares Statistics:
According to the various share statistics, ALHC traded on average about 909.05K shares per day over the past 3-months and 777040 shares per day over the past 10 days. A total of 188.95M shares are outstanding, with a floating share count of 90.72M. Insiders hold about 52.41% of the company’s shares, while institutions hold 40.94% stake in the company. Shares short for ALHC as of 1713139200 were 4690887 with a Short Ratio of 5.16, compared to 1710460800 on 4780744. Therefore, it implies a Short% of Shares Outstanding of 4690887 and a Short% of Float of 3.9300002000000003.
Earnings Estimates
The current market rating for Alignment Healthcare Inc (ALHC) reflects the collective analysis of 11.0 analysts closely monitoring its performance.On average, analysts expect EPS of -$0.22 for the current quarter, with a high estimate of -$0.14 and a low estimate of -$0.26, while EPS last year was -$0.2. The consensus estimate for the next quarter is -$0.11, with high estimates of -$0.06 and low estimates of -$0.16.
Analysts are recommending an EPS of between -$0.3 and -$0.75 for the fiscal current year, implying an average EPS of -$0.58. EPS for the following year is -$0.48, with 11.0 analysts recommending between -$0.21 and -$0.66.
Revenue Estimates
According to 10 analysts, the current quarter’s revenue is expected to be $597.48M. It ranges from a high estimate of $609.1M to a low estimate of $594.88M. As of the current estimate, Alignment Healthcare Inc’s year-ago sales were $439.15MFor the next quarter, 10 analysts are estimating revenue of $607.3M. There is a high estimate of $624M for the next quarter, whereas the lowest estimate is $586.4M.
A total of 10 analysts have provided revenue estimates for ALHC’s current fiscal year. The highest revenue estimate was $2.47B, while the lowest revenue estimate was $2.38B, resulting in an average revenue estimate of $2.41B. In the same quarter a year ago, actual revenue was $1.82BBased on 10 analysts’ estimates, the company’s revenue will be $2.9B in the next fiscal year. The high estimate is $3.21B and the low estimate is $2.75B.
